Biotech

All Articles

Enanta's RSV antiviral crushes virus-like lots in obstacle research study

.Enanta Pharmaceuticals has connected its own respiratory system syncytial virus (RSV) antiviral to ...

Biogen cans SAGE-324 cooperation after vital tremor fail

.Biogen has actually administered the final ceremonies to its cooperation along with Sage Rehabs on ...

AbbVie Parkinson's drug from $8.7 B Cerevel buyout ratings

.On the same time that some Parkinson's health condition medications are actually being brought into...

Arch shuts $3B-plus fund to promote biopharma upstarts

.On the heels of a $3 billion fund from Bain Capital Life Sciences, Arc Venture Partners is proving ...

Orion to utilize Aitia's 'digital twins' to locate new cancer medications

.Finnish biotech Orion has actually snooped possible in Aitia's "electronic identical twin" tech to ...

Windtree's shock med increases blood pressure in most recent period 2 win

.While Windtree Therapies has strained to grow the financial roots needed to make it through, a peri...

2 cancer cells biotechs merge, creating international footprint

.OncoC4 is actually taking AcroImmune-- as well as its own in-house scientific manufacturing capabil...

Amgen documents very first phase 3 gain for $400M chronic eczema medication

.Amgen has actually shared (PDF) the first phase 3 records on its own $400 thousand dermatitis medic...

Biogen, UCB record phase 3 lupus gain after failing earlier test

.Biogen and UCB's bank on improving right into period 3 on the back of a broken research wants to ha...

Aptadir really hopes new RNA preventions can easily reverse complicated cancers

.Italian biotech Aptadir Therapies has actually launched along with the guarantee that its pipe of p...